Neurol. pro Praxi, 2004; 4: 222-225

Migréna - diagnostika a akutní terapie záchvatů

MUDr. Eva Medová
Neurologická klinika 3. LF UK a FN KV, Praha

Keywords: primární bolesti hlavy, anamnéza, aura, provokační faktory, akutní léčba, specifická antimigrenika, triptany, ergotamin.

Published: December 31, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Medová E. Migréna - diagnostika a akutní terapie záchvatů. Neurol. praxi. 2004;7(4):222-225.

Migréna je záchvatovité chronické onemocnění, projevující se bolestmi hlavy naprosto typického charakteru i průběhu záchvatu. Má své specifické provokační faktory a doprovodné příznaky. Základem správné diagnózy je pečlivá anamnéza, neboť neexistuje žádné pomocné vyšetření, které by migrénu jednoznačně vyloučilo či potvrdilo. Léčbu migrény dělíme na akutní - potlačující bolest při vlastním záchvatu, a preventivní, která snižuje frekvenci a mnohdy i intenzitu záchvatů. V akutní léčbě jsou lékem volby specifická antimigrenika - triptany a ergotaminové preparáty. Při volbě vhodného léku se řídíme tíží záchvatu a doprovodnými příznaky.

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ahrens SP, Farmer MV, Williams DL, Willoughby E, Jiang K, Block GA, Visser WH, and the Rizatriptan Wafer Protocol 049 Study Group. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Cephalalgia 1999: 19: 525-530. Go to original source... Go to PubMed...
    2. Anonymus. Zomig (Zolmitriptan), International Monograph. Cheshire: Zeneca Pharmaceutical, 1997: 97.
    3. Doležil D, Doležal T. naratriptanum. REMEDIA 13, 2003, 308-311. Go to original source...
    4. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans in acute migraine treatment: a meta analysis of 53 trials. Lancet 2001; 358: 1668-1675. Go to original source... Go to PubMed...
    5. Gallagher RM. Emergency treatment of intractable migraine. Headache 1986: 26: 74-75. Go to original source... Go to PubMed...
    6. Goldstein J, Ryan R, Jiang K, eds. Crossover Comparison of Rizatriptan 5 mg and 10 mg versus Sumatriptan 25 mg and 50 mg in Migraine. Headache 1998; 38: 737-747. Go to original source...
    7. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders. Cephalalgia, Volume 24, Supplement 1, 2004: 24-25, 31-32.
    8. Klapper JA, Stanton JS. The emergency treatment of acute migraine headache: A comparison of intravenous dihydroergotamine, dexamethasone, and placebo. Cephalagia 1991; 11: 159-160. Go to original source...
    9. Kotas R. a kol.: Migréna, patofyziologie a léčba. Praha. Maxdorf, 2001; str. 109, 121-122.
    10. Kozubski W. Metamizole and hydrocortisone for the interruption of a migraine attacks-preliminary study. Headache 1992; 3: 326-328.
    11. Lipton RB, JAMA 2000; 284 (20): 2599-2605.
    12. Longmore J. Pharmacology and Preclinical Mechanisms of Action of Rizatriptan. In: Bousser MG. Rizatriptan: A new Milestone in Migraine Treatment. MSD Satellite Symposium Nice 1998, France. Whitehouse Station, USA: Merk, 1998: 6.
    13. Medová E. Léčiva používaná v terapii migrény. REMEDIA 3/2003, 223-228.
    14. Seymour D (a komentář Waberžinek). Soudobé názory na léčbu migrény. Medicína po promoci, 2, 2001; 4: 59-65.
    15. Silberstein D, Saper JR, Freitag G. Migraine: Diagnosis and treatment. In Wolffś Headache and other head pain. Seventh edition. USA: Oxford University Press 2001: 174. Go to original source...
    16. Teall J, Tuchman M, Cutler N, eds. Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo-Controlled, Outpatient Study. Headache 1998; 38: 173-183. Go to original source... Go to PubMed...
    17. The International 311 C90 Long-term Study Group. The Long-term Tolerability and Efficacy of Oral Zolmitriptan (Zomig, 311 C90) in the Acute Treatment of Migraine. An International Study. Headache 1998; 38: 173-183. Go to original source...
    18. Waberžinek G. Bolesti hlavy. Nakladatelství Triton, 2000: 79.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.